What NOVA Has Learned: Experiment Aggregation and Corpus Integrity
How repeated wins, failures, and changed conditions become bounded evidence
schema 1 · revision 1How NOVA combines Experiment Mode results without hiding failed runs, mistaking repeated targets for independent evidence, or pooling across material version changes.
What learning means here
NOVA learns by retaining versioned experiment evidence and finding bounded tendencies in comparable groups of runs. It does not train a mysterious universal model from winner rows. The public unit of evidence remains a traceable run: its input state, candidates, effective treatments, measurements, evaluator, decision, and terminal outcomes.
Why the denominator matters
A selection count is meaningful only alongside everything that had a chance to contribute. Before an aggregate win percentage can be strong evidence, the corpus must represent successful comparisons, execution failures, all-failed and aborted runs, analytic rejections, no-op wins, single-survivor outcomes, and inconclusive comparisons. A single survivor may show fallback reliability, but it did not comparatively defeat candidates that never produced a valid result.
Every figure names its denominator: total attempted runs, comparable concluded runs, candidate exposures, execution successes, rejections, selections, controls, and inconclusive outcomes as relevant. Rows stored only for successful variants are historical records, not proof that every attempted run was counted.
Comparable runs and independent targets
Ten reruns or reprocessing branches of the same target are not ten independent targets. Summaries report both counts and keep same-target reruns distinct from evidence spanning independent targets. Runs are pooled only when their process family, input state, data class, candidate set, adaptation policy, measurement system, and relevant image conditions support the same bounded question.
If a treatment helps one morphology but harms another, the result becomes class-specific guidance. A global percentage must not erase that reversal or let an overrepresented class choose the apparent winner.
What counts as the same experiment
A candidate name alone is not treatment identity. Effective parameters, masks, adaptation policy, candidate-set revision, code and tool versions, metric implementation, evaluator model, prompt, preview transform, visible candidate identity, and historical-prior exposure can all change what was tested or how it was judged.
When any of those identities changes materially, NOVA partitions the evidence into a new versioned stratum unless compatibility has been demonstrated. Operational history influenced by earlier preferences is disclosed, and stronger generalized claims need some prior-hidden or blind evidence rather than treating a self-reinforcing sequence as independent replication.
Versions travel with the evidence
Tool and model versions are recorded at aggregation time, along with the other identities that materially define the treatment and evaluation. If a generating version later changes enough to break comparability, its entries remain visible but are flagged stale or version-bound. They are not silently folded into totals for the current version.
What NOVA can summarize
With a complete denominator, NOVA can responsibly report counts of exposures, successes, failures, rejections, selections, no-op wins, inconclusive runs, independent targets, and review disagreements. A selection frequency is written as a descriptive count such as 'selected in 8 of 12 comparable runs across 6 targets,' never as '80% confidence.'
Where a process-valid measurement exists, paired same-parent effects and preservation checks usually say more than a winner percentage. More observations do not turn a weak or gameable proxy into scientific validation, and formal intervals or tests wait until the sampling unit, estimand, dependence, and comparability assumptions are justified.
How a recommendation matures
Evidence progresses from research candidate, to execution-confirmed, experimented, promising in a defined class, preferred in a defined class, and finally recommended or default. A run proves execution; one comparison supports only a run-local observation. Preference requires complete negative evidence, stable treatment identity, multiple independent targets, valid measurements, preservation checks, evaluator provenance, and no unresolved material contradiction in the stated class.
There is no magic run count or winner percentage. Applicability, target diversity, effect consistency, failure rate, measurement validity, and dependence determine what the evidence can carry.
Negative results stay visible
Execution failures, artifact rejections, degraded measurements, preservation failures, no-op wins, version regressions, and inconclusive outcomes are part of what NOVA learned. Conflicting evidence qualifies or splits a claim; it is not averaged away or overwritten by the newest result.
The current limit
NOVA's existing experiment history contains useful run-level ingredients, but it is not automatically a complete experiment registry. Until attempted candidates and every terminal outcome are known to be represented, the Handbook does not publish raw historical winner data as a generalized leaderboard or a statistical confidence model.
Auditable claims
NOVA does not publish an aggregate selection percentage as strong evidence until its denominator includes failures, all-failed runs, no-op selections, single survivors, and inconclusive outcomes; every reported figure names the matching comparable-run or candidate-exposure denominator.
source-confirmed · noneRepeated runs on one target are dependent reruns, not independent-target replication. A corpus summary reports both run count and independent target count rather than letting one stand in for the other.
source-confirmed · noneA selection frequency over a complete, comparable stratum is a descriptive property of that recorded corpus, not statistical confidence, a posterior probability, or proof that a treatment is best.
historical-win-fraction · noneWhen code, tool, model, evaluator, prompt, metric, or effective treatment identity changes materially, NOVA partitions the evidence into a new stratum unless compatibility is established; it does not silently fold the old results into current totals.
source-confirmed · noneAggregation records the relevant tool and model versions. Evidence produced by a materially superseded version remains visible as stale or version-bound history rather than being presented as current.
source-confirmed · noneFailures, analytic rejections, no-op wins, preservation failures, and class-specific reversals are first-class evidence. Contradictions split or qualify a claim instead of being averaged out of view.
repeated-evidence · unresolved